| Tretinoin | Approved Investigational Nutraceutical | SLC25A35 | 399512 |
upregulated | Tretinoin results in increased expression of SLC25A35 mRNA | 17p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC25A37 | 51312 |
upregulated | Tretinoin results in increased expression of SLC25A37 mRNA | 8p21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC25A43 | 203427 |
downregulated | Tretinoin results in decreased expression of SLC25A43 mRNA | Xq24 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC26A10 | 65012 |
downregulated | Tretinoin results in decreased expression of SLC26A10 mRNA | 12q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC26A2 | 1836 |
downregulated | Tretinoin results in decreased expression of SLC26A2 mRNA | 5q32 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC27A2 | 11001 |
downregulated | Tretinoin results in decreased expression of SLC27A2 mRNA | 15q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC27A6 | 28965 |
downregulated | Tretinoin results in decreased expression of SLC27A6 mRNA | 5q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC29A1 | 2030 |
downregulated | Tretinoin results in decreased expression of SLC29A1 mRNA | 6p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC29A1 | 2030 |
upregulated | Tretinoin results in increased expression of SLC29A1 mRNA | 6p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC29A3 | 55315 |
upregulated | Tretinoin results in increased expression of SLC29A3 mRNA | 10q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC2A1 | 6513 |
downregulated | Tretinoin results in decreased expression of SLC2A1 mRNA | 1p34.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC2A10 | 81031 |
downregulated | Tretinoin results in decreased expression of SLC2A10 mRNA | 20q13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC2A3 | 6515 |
downregulated | Tretinoin results in decreased expression of SLC2A3 mRNA | 12p13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC2A3 | 6515 |
upregulated | Tretinoin results in increased expression of SLC2A3 mRNA | 12p13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC2A4RG | 56731 |
upregulated | Tretinoin results in increased expression of SLC2A4RG mRNA | 20q13.33 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC2A5 | 6518 |
upregulated | Tretinoin results in increased expression of SLC2A5 mRNA | 1p36.23 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC30A10 | 55532 |
downregulated | Tretinoin results in decreased expression of SLC30A10 mRNA | 1q41 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC31A1 | 1317 |
upregulated | Tretinoin results in increased expression of SLC31A1 mRNA | 9q32 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC31A2 | 1318 |
upregulated | Tretinoin results in increased expression of SLC31A2 mRNA | 9q32 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC32A1 | 140679 |
upregulated | Tretinoin results in increased expression of SLC32A1 mRNA | 20q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC35F1 | 222553 |
downregulated | Tretinoin results in decreased expression of SLC35F1 mRNA | 6q22.2-q22.31 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC35F2 | 54733 |
downregulated | Tretinoin results in decreased expression of SLC35F2 mRNA | 11q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC35F2 | 54733 |
upregulated | Tretinoin results in increased expression of SLC35F2 mRNA | 11q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC35F3 | 148641 |
downregulated | Tretinoin results in decreased expression of SLC35F3 mRNA | 1q42.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC35G1 | 159371 |
upregulated | Tretinoin results in increased expression of SLC35G1 mRNA | 10q23.33 | |